MEDP Stock Recent News
MEDP LATEST HEADLINES
Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.
Medpace (MEDP) came out with quarterly earnings of $3.20 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.27 per share a year ago.
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Uber, Axon and one more stock with the highest-possible rating from IBD lead this weekend's watch list.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Trip.com Group Limited (TCOM), Medpace (MEDP), Centrus Energy (LEU) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
While February is generally known to be a bit cold, these three stocks have been red-hot, rewarding investors considerably following strong quarterly results.